Builds neuromodulation wristbands to treat physical symptoms of nausea without pharmaceuticals.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
ReliefBand Technologies manufactures and distributes clinically proven wearable electronic devices designed to alleviate symptoms of nausea, retching, and vomiting. The drug-free therapeutic technology utilizes precise neuromodulation pulses that target the median nerve on the user’s wrist to regulate gastric signals through the nervous system.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
ReliefBand Technologies Management Team
Investors
PathoCapital
ReliefBand Technologies Valuations & Financials
View real-time NPM data on ReliefBand Technologies stock including daily ReliefBand Technologies stock price estimates, valuation history, and historical share price information. Access ReliefBand Technologies financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track ReliefBand Technologies pricing across six independent market signals. Looking for private company due diligence data sources on ReliefBand Technologies? Get in touch to learn more.
Similar Companies
like ReliefBand Technologies
Voom Medical Devices
Healthcare & Life Sciences
Restores mobility and fixes bunions using fusion-free screws and minimally invasive procedures for faster recovery and better function.
Renalis
Healthcare & Life Sciences
Creates mobile prescription digital therapeutics that deliver behavioral therapy for pelvic health disorders to improve patient outcomes.
Candid Therapeutics
Healthcare & Life Sciences
Develops innovative therapies that utilize T-cell engager antibodies to selectively eliminate autoreactive B-cells.
Alli Connect
Healthcare & Life Sciences
Connects individuals with therapists, peer support tools, and digital resources to improve proactive mental wellness.
Actium Health
Healthcare & Life Sciences
AI-powered patient engagement platform that generates personalized outreach and care actions using AI-driven data intelligence.
Sesame
Healthcare & Life Sciences
Direct-to-consumer healthcare platform offering affordable telehealth and in-person medical services with transparent pricing, no insurance required.
KromaTiD
Healthcare & Life Sciences
Delivering single-cell cytogenetic clarity for gene editing and cell therapies with high-confidence genome integrity analysis.
Firefly Bio
Healthcare & Life Sciences
Create cancer therapies that use Degrader Antibody Conjugates to precisely deliver payloads and degrade target proteins while minimizing collateral damage.
Bennie
Healthcare & Life Sciences
Digital platform streamlines employee benefits management, offering health plans and insurance solutions to optimize workplace benefits delivery.
FAQ
We have answers
ReliefBand Technologies stock does not trade on public stock exchanges. ReliefBand Technologies stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ReliefBand Technologies stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
ReliefBand Technologies Stock does not trade on public stock exchanges. In order to sell ReliefBand Technologies shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
ReliefBand Technologies does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view ReliefBand Technologies share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for ReliefBand Technologies stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ReliefBand Technologies stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ReliefBand Technologies stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
ReliefBand Technologies is a private company and has not had an IPO. There is currently no ReliefBand Technologies IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to ReliefBand Technologies IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
